Mingyan Zhuang

No ORCID on file · 3 papers in corpus · active 2020-2023

Study types

  • article 3

Condition tags

  • adenomyosis 2
  • endometriosis 1
article 2023
An insight into gut microbiota and metabolites in the mice with adenomyosis
Frontiers in cellular and infection microbiology ·doi:10.3389/fcimb.2023.1075387

BACKGROUND: Adenomyosis (AM) is a benign uterine disease characterized pathologically by the invasion of endometrial tissue into the myometrium. The pathogenesis of AM is still far from clear. Although the gut microbiome and metabolomics ar…

article 2021
Utilizing network pharmacology and molecular docking to explore the underlying mechanism of Guizhi Fuling Wan in treating endometriosis
PeerJ ·doi:10.7717/peerj.11087

BACKGROUND: Guizhi Fuling Wan (GZFLW) is a widely used classical Chinese herbal formulae prescribed for the treatment of endometriosis (EMs). This study aimed to predict the key targets and mechanisms of GZFLW in the treatment of EMs by net…

article 2020
[Study on mechanism of Rhei Radix et Rhizoma-Persicae Semen in treatment of adenomyosis based on network pharmacology].
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica ·doi:10.19540/j.cnki.cjcmm.20200520.403

The aim of this paper was to screen the active targets of Rhei Radix et Rhizoma and Persicae Semen in the treatment of adenomyosis(AM) by means of network pharmacology, and to investigate their mechanism of action. The effective components …